Using global burden of hepatocellular cancer and liver cirrhosis as a driver to tackle preventable mortality and morbidity nationally and regionally

Affiliations

¹ Gastroenterology and Liver Units, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, National Institute of Health Research Biomedical Research Centre and Centre for Liver and Gastroenterology Research, University of Birmingham, Birmingham, UK.

Editorial

Neeraj Bhala et al. Hepatology. 2023.

. 2023 Apr 1;77(4):1078-1080.

doi: 10.1097/HEP.0000000000000011. Epub 2023 Feb 3.

¹ Gastroenterology and Liver Units, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham, National Institute of Health Research Biomedical Research Centre and Centre for Liver and Gastroenterology Research, University of Birmingham, Birmingham, UK.

No abstract available

Comment on

Global burden of liver cancer in males and females: Changing etiological basis and the growing contribution of NASH.
Tan DJH, Setiawan VW, Ng CH, Lim WH, Muthiah MD, Tan EX, Dan YY, Roberts LR, Loomba R, Huang DQ. Tan DJH, et al. Hepatology. 2023 Apr 1;77(4):1150-1163. doi: 10.1002/hep.32758. Epub 2022 Sep 12. Hepatology. 2023. PMID: 36037274

1. Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380:1450-1462.
1. Tan DJH, Setiawan VW, Ng CH, Lim WH, Muthiah MD, Tan EX, et al. Global burden of liver cancer in males and females: changing etiological basis and the growing contribution of NASH. Hepatology. 2023;77:1150–63.
1. Liu Y, Zheng J, Hao J, Wang RR, Liu X, et al. Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019. Cancer Med. 2022;11:1310–1323.
1. Fujiwara N, Friedman SL, Goossens N, Hoshida Y. Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine. J Hepatol. 2018;68:526-549.
1. Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study. BMJ. 2018;362:k2817.